Lavoisier S.A.S.
14 rue de Provigny
94236 Cachan cedex
FRANCE

Heures d'ouverture 08h30-12h30/13h30-17h30
Tél.: +33 (0)1 47 40 67 00
Fax: +33 (0)1 47 40 67 02


Url canonique : www.lavoisier.fr/livre/medecine/direct-oral-anticoagulants/descriptif_4550140
Url courte ou permalien : www.lavoisier.fr/livre/notice.asp?ouvrage=4550140

0 article 

 Frais de port 0,01€*

Exclusivité web : à partir de 35 euros d’achat, frais de port à 1 centime pour les expéditions vers la France métropolitaine, la Suisse et l’UE avec Colissimo ou GLS

Direct Oral Anticoagulants, 1st ed. 2021 From Pharmacology to Clinical Practice

Langue : Anglais

Coordonnateurs : Proietti Riccardo, AlTurki Ahmed, Ferri Nicola, Russo Vincenzo, Bunch T. Jared

Couverture de l’ouvrage Direct Oral Anticoagulants

This book concisely covers the latest developments in the application of direct oral anticoagulants (DOACs) within cardiovascular medicine. It details the pharmacodynamics and pharmacokinetic mechanisms of DOACs and their application in treating patients with conditions ranging from coronary heart disease through kidney disease and cancer, including their perioperative management. 

Direct Oral Anticoagulants: From Pharmacology to Clinical Practice systematically describes the underlying mechanisms associated with DOACs and their use to treat a range of conditions and is an indispensable resource for all trainee and practicing physicians in a range of disciplines seeking a concise up-to-date resource on the topic.  



Chapter 1. The Coagulative cascade
Chapter 2 Clinical Indications for Direct Acting Oral Anticoagulants
Chapter 3. Pharmacokinetic and pharmaco-dynamic of DOAC
Chapter 4. Drug-drug interaction with DO-ACs
Chapter 5. Direct Oral Anticoagulant Reversal for Management of Bleeding and Emergent Surgery
Chapter 6. Risk stratification for and use of DOAC therapies for stroke prevention in patient with atrial fibrillation
Chapter 7. Use of DOAC in patients with kidney disease
Chapter 8. Anticoagulation In Elderly Patients With Atrial Fibrallation
Chapter 9. The “Obesity Paradox” And The Use Of NOAC
Chapter 10. Direct Oral Anticoagulation In Cancer Patients
Chapter 11. DOACs and Dementia in Patients with Atrial Fibrillation
Chapter 12. Non-Vitamin K Antagonists and Cardiac Implantable Electronic Devices
Chapter 13. Direct Oral Anticoagulants and Atrial Fibrillation Ablation
Chapter 14. DOAC therapy in patients post left atrial appendage occlusion or isolation
Chapter 15. Use of Direct Oral Anticoagulants after Transcatheter Aortic Valve Replacement
Chapter 16. Use of Direct Oral Anticoagulants after Percutaneous Coronary Intervention
Chapter 17: Direct oral anticoagulants and Left Ventricular Thrombosis: the evidence for a good therapeutic approach
Dr. Riccardo Proietti MD, PhD, graduated at the Catholic University of Rome in 1997. He then specialized in cardiology at the University of Perugia and achieved a PhD degree in Cardiovascular Science at the University of Padua. He accomplished a fellowship in clinical electrophysiology at McGill University Canada. Since 2010, he is Consultant Cardiologist at Luigi Sacco Hospital of Milan with main activity in cardiac pacing and electrophysiology. He is certified in cardiac pacing by the European Heart Rhythm society and in Clinical Electrophysiology by the Heart Rhythm Society. He is author of articles in national and international peer-reviewed journals and a number of book chapters.

Ahmed AlTurki completed internal medicine residency and a fellowship in cardiology at McGill University in Montreal, Canada and is currently undertaking a fellowship in cardiac electrophysiology at the same institution. His main scientific interests include oral anticoagulation for atrial fibrillation, cardiac implantable electronic devices and catheter ablation of atrial fibrillation. He has authored over peer-reviewed journal articles and several book chapters.

Nicola Ferri is Associate Professor in Pharmacology at the University of Padua. His main scientific interest is focused on drugs affecting lipid metabolism and atherosclerosis. He received several honours, among all the award “Giovani Ricercatori” by Italian Society for the study of atherosclerosis (SISA). He is elected in the organizing committee of the European Lipoprotein Club meeting (from 2017 until 2011) and of SISA Veneto section (from 2018-2022). He is authors of more than 100 peer-review manuscripts.

Vincenzo Russo undertook specialist training in Cardiology at Monaldi Hospital. He earned PhD degree in Pathophysiology of the Cardio-Respiratory System from Second University of Naples in 2013. Since 2010, Dr. Russo serves as Consultant Cardiologis

Assesses important drug-drug interactions in patients with chronic kidney disease and cancer

Provides concise easy to digest information on the use of DOACs in perioperative management

Details the application of DOACs in elderly patients

Date de parution :

Ouvrage de 283 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

116,04 €

Ajouter au panier

Date de parution :

Ouvrage de 283 p.

15.5x23.5 cm

Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).

158,24 €

Ajouter au panier